Abstract
The aim of this study was to understand the effect of high shear homogenization (HSH) and ultrasonication (US) on the physicochemical properties of blank and olanzapine loaded nanostructured lipid carriers (NLCs) along with their drug loading potential and drug release profiles from formulated particles. NLCs were prepared with different ratios of Compritol and Miglyol as the solid and liquid lipids, respectively, under changing HSH and US times between 0 to 15 min. The surfactants (Poloxamer 188 (P188) and tween 80) and the drug content was kept constant in all formulations. The prepared NLCs were evaluated for particle size, polydispersity index, zeta potential, drug crystallinity and chemical interactions between lipids and OLZ. The in-vitro drug release was performed using dialysis tube method in phosphate buffer solution (PBS) at pH 7.4. The formulated NLCs were negatively charged, spherically shaped and monodisperse, with particle sizes ranging from 112 to 191 nm. There was a significant influence of US time on the preparation of NLCs in comparison to HSH, where a significant reduction in the mean particle diameter was seen after 5 min of sonication. An increase of Miglyol content in NLCs led to an increase in particle size. In general, application of US led to decrease in particle size after HSH but an increase in particle diameter of low Miglyol containing preparation was also observed with longer sonication time. OLZ was successfully encapsulated in the NLCs and a total release of 89% was achieved in 24 h in PBS at pH 7.4.
Highlights
The need for suitable alternatives to conventional drug delivery systems has led to a rising interest in lipid-based formulations
The solid lipid composition (Figure 1) of Solid lipid nanoparticles (SLNs) results in their perfect crystalline core, which often results in less space available for drug loading
The aim of this study was to understand the effect of high shear homogenization (HSH) and US on the development of nanostructured lipid carriers (NLCs) containing Compritol® and Miglyol and its effect on the particle size and surface charge
Summary
The need for suitable alternatives to conventional drug delivery systems has led to a rising interest in lipid-based formulations. Lipid nanoparticles (LNPs) are known to have a high drug encapsulation efficiency, high stability and are generally inexpensive to produce [1]. As these lipid systems can be prepared without organic solvents and are made up of lipids similar to those found in the human body, they are considered to be biocompatible, biodegradable and non-toxic [1,2]. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) are two main types of LNPs [1] Both lipid systems are prepared using pure lipids or a blend of lipidic compounds (e.g., triacylglycerols, fatty acids and oils), and a single surfactant (or combined with a co-surfactant) surrounding the particles.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
